Background {#Sec1}
==========

Ankle osteoarthritis is a slowly progressive destructive disease inducing pain, dysfunction, impaired mobility, and decreased quality of life \[[@CR1]\]. Compared to ankle arthrodesis, total ankle arthroplasty (TAA) can preserve gait motion by restoring closer to normal joint motion and improve patient satisfaction by reducing pain while minimizing subtalar joint arthritis \[[@CR2]--[@CR8]\]. Several recent studies reported satisfactory outcomes of TAA, these promising outcomes have led TAA as a primary treatment option for ankle osteoarthritis \[[@CR9]--[@CR20]\].

Various predisposing factors including age, gender, and preoperative deformity can affect the outcome of TAA \[[@CR10], [@CR12], [@CR18], [@CR21]--[@CR24]\]. In relation to gender difference, several studies demonstrated divergent clinical outcomes following total hip or total knee arthroplasty. In total hip arthroplasty, some studies reported no difference in all postoperative outcome measures between men and women \[[@CR25]\]. On the other hand, another study reported that gender-related analysis resulted in significantly higher scores for men compared to women \[[@CR26]\]. Recent meta-analysis demonstrated that men showed a higher risk of revision after primary total hip arthroplasty due to any cause, infection, or aseptic loosening, when compared to women \[[@CR27]\]. In terms of total knee arthroplasty, several studies reported that functional outcomes were different between men and women \[[@CR28]--[@CR30]\]. On the contrary, another study suggested that gender does not seem to affect clinical outcome \[[@CR31]\].

However, no study has been conducted examining the outcomes of gender-based differences in TAA. We hypothesize that clinical and radiographic outcomes for TAA would be comparable between men and women patients. Thus, the purpose of the present study was to compare intermediate-term clinical and radiographic outcomes, survivorship, and complications rates of TAA in patients with end-stage ankle osteoarthritis according to gender differences.

Materials and methods {#Sec2}
=====================

This study was approved by the Institutional Review Board of our hospital. Informed consent was obtained from all patients. Between January 2005 and December 2015, a total of 243 consecutive primary TAA were performed in 231 patients using cementless three-component HINTEGRA prosthesis (Newdeal, Lyon, France/Integra Lifesciences, Plainsboro, NJ, USA). Inclusion criteria were symptomatic end-stage ankle osteoarthritis with a minimum follow-up of 48 months after TAA, and fulfillment of general total ankle arthroplasty indications including good bone stock and normal neurovascular status. Patients were excluded from the trial if they had any of the following: secondary osteoarthritis due to osteonecrosis of the talus or pigmented villonodular synovitis; arthritis caused by systemic disease, such as rheumatoid arthritis and hemophilia; and previous history of infectious arthritis or ankle arthrodesis.

Finally, we enrolled 187 patients (195 ankles) who underwent primary TAA. We divided the patients into two groups according to gender: (1) men's group (106 patients, 109 ankles) and (2) women's group (81 patients, 86 ankles). Patients in each group showed similar characteristics in mean age, preoperative diagnosis, and follow-up duration (Table [1](#Tab1){ref-type="table"}). Table 1Comparison of patient demographics between men and womenMen (*N* = 109 ankles)Women (*N* = 86 ankles)*p* value\***Age (year)**†65.4 ± 7.3 (45 to 82)63.2 ± 7.2 (47 to 83)0.114**BMI (kg/m**^**2**^**)**†25.3 ± 2.3 (20.5 to 31.8)25.6 ± 2.7 (19.1 to 32.0)0.111**Diagnosis**‡0.277 Primary osteoarthritis40 (36.7%)31 (36.0%) Recurrent ankle sprain35 (32.1%)20 (23.3%) Post-fracture34 (31.2%)35 (40.7%)**Follow-up (months)**†90.3 ± 32.6 (48 to 170)89.6 ± 32.9 (50 to 174)0.887*BMI* body mass index**\***The independent *t* test was used to analyze age differences in age, BMI, and follow-up duration. The chi-square test was used to analyze differences in preoperative diagnoses. A *p* value of \< 0.05 was considered significant†The values are given as the mean ± standard deviation, with the range in parentheses‡The values are given as the number of ankles, with the percentage in parentheses

Surgical technique and postoperative management {#Sec3}
-----------------------------------------------

Patients underwent TAA with HINTEGRA prosthesis by a single surgeon, with use of a longitudinal anterior approach between the anterior tibial tendon and the extensor hallucis longus, with the patient in the supine position. After removal of anterior capsular synovial tissue and osteophytes, the tibial cut was performed perpendicular to the mechanical axis of the tibia. The talus bone cut was made parallel to the tibial cut; then, the medial, lateral, and posterior talar cuts were made. After selected components had been inserted, the alignment, stability, joint motion, and implant position were checked by an image intensifier. Hindfoot alignment and ligamentous stability were rechecked. Concomitant procedures were done to obtain neutral alignment, stability, and ligamentous balance, if necessary.

Postoperatively, for the first postoperative 2 weeks, a short leg splint was worn and patients maintained non-weight-bearing with neutral ankle positions. For the next 4 weeks, patients were allowed to begin range of motion (ROM) exercises. At 6 weeks after surgery, progressive weight-bearing ambulation was initiated with ankle-foot orthosis. The rehabilitation protocol differed slightly if additional procedures were performed at the index surgery.

Clinical evaluation {#Sec4}
-------------------

Ankle Osteoarthritis Scale (AOS) pain and disability \[[@CR32]\], American Orthopaedic Foot and Ankle Society (AOFAS) ankle-hindfoot scoring system \[[@CR33]\], Short Form (SF)-36 Physical Component Summary score (PCS) \[[@CR34]\], and visual analog scale (VAS) for pain were administered to the patients for assessment of clinical outcomes. ROM of ankle joint, including degree of dorsiflexion and plantar flexion was measured using a goniometer along the lateral border of the leg and foot. The main outcomes were assessed based on the AOS, because it was reliable, validated, and an ankle joint-specific measurement, and it is clinically important to evaluate whether the AOS improved beyond the minimal clinically important difference (MCID). The MCID is the smallest change in outcome assessment in patient who identified themselves as minimally better or worse after surgical procedure \[[@CR35]\]. The AOFAS scoring system, a combination of subjective and objective data, was used as secondary assessment tool. SF-36 scores and VAS pain were utilized as comparative measures.

This study noted postoperative complications, and these were divided into major and minor. Major complications included deep infection, periprosthetic osteolysis, and its associated complication. Minor complications included wound problems and heterotopic ossification \[[@CR36], [@CR37]\]. We defined failure when either the tibial or talar metallic component was replaced \[[@CR22]\].

Radiographic evaluation {#Sec5}
-----------------------

Radiographic examination included anteroposterior and lateral radiographs of the ankle on full weight-bearing, taken preoperatively and postoperatively. Follow-up radiographs were taken at 1, 3, 6, and 12 months postoperatively, and annually thereafter. The coronal plane alignment was determined from the angle formed between the anatomical axis of the tibia and a line perpendicular to the talus or talar component. For the radiographic analysis, measurements were made using a PACS (picture archiving and communication system: Maroview 5.4; INFINITT Healthcare). To minimize measurement errors, by two independent observers measured radiographic values twice and the mean of the remaining values except the maximum and the minimum was reported.

Statistical analysis {#Sec6}
--------------------

Descriptive statistics were calculated by use of standard formulas. A Kolmogorov-Smirnov test was used to verify that data were normally distributed. For normally distributed variables, the independent *t* test was used to determine the significance of intergroup differences. The Mann-Whitney *U* test was used to analyze differences when there was a lack of normality. For the categorical variables, chi-square test or Fisher's exact test was used to analyze differences. Data were analyzed using SPSS version 23.0 (IBM Corp., Armonk, NY, USA). Statistical significance was accepted for *p* values \< 0.05, and all components of the statistical analysis were reviewed by a statistician.

Results {#Sec7}
=======

Clinical outcomes {#Sec8}
-----------------

The clinical outcome details are provided in Table [2](#Tab2){ref-type="table"} (Fig. [1](#Fig1){ref-type="fig"}). The mean preoperative AOS pain scores were 57.6 points in men and 58.6 points in women, and these were improved to 17.6 and 22.4 points, respectively, at final follow-up. The mean AOS disability scores were 67.3 points in men and 65.2 points in women, and these were improved to 28.3 and 32.1 points, respectively, at final follow-up. According to a previous study \[[@CR35]\], the MCID of the total AOS (mean of AOS pain and disability) was 28.0 points. In the present study, the mean improvement of the total AOS was 39.5 points in men and 34.7 points in women. Therefore, the two groups showed clinically meaningful improvement after TAA. The preoperative AOFAS scores were improved to 88.3 points in men and 83.9 points in women at final follow-up. The SF-36 PCS was improved by 23.2 points in men and 8.8 points in women. The VAS pain score was also improved to 1.7 points in men and 2.0 points in women at final follow-up. There was no significant difference in clinical outcomes and ROM between the two groups at the final follow-up, except for SF-36 PCS (*p* \< 0.05). Table 2Clinical outcomes of the men and women groupsMen (*N* = 109 ankles)Women (*N* = 86 ankles)*p* value\***AOS pain**† Preoperative57.6 ± 14.9558.6 ± 17.360.907 Final follow-up17.6 ± 19.2922.4 ± 21.370.178**AOS disability**† Preoperative67.3 ± 11.2965.2 ± 14.630.669 Final follow-up28.3 ± 20.8832.1 ± 23.050.366**AOFAS ankle-hindfoot score**† Preoperative51.0 ± 13.9252.3 ± 12.540.573 Final follow-up88.3 ± 11.9983.9 ± 15.160.060**SF-36 PCS score**† Preoperative41.9 ± 15.9246.7 ± 16.450.149 Final follow-up65.2 ± 22.3255.4 ± 25.050.027**VAS pain**† Preoperative6.8 ± 1.837.0 ± 1.610.534 Final follow-up1.7 ± 2.282.0 ± 2.250.272**ROM, dorsiflexion (°)**† Preoperative9.8 ± 6.209.6 ± 5.440.877 Final follow-up10.5 ± 6.2411.3 ± 5.120.381**ROM, plantar flexion (°)**† Preoperative21.4 ± 10.0923.9 ± 9.940.138 Final follow-up22.8 ± 11.2825.6 ± 9.840.170*AOS* Ankle Osteoarthritis Scale, *AOFAS* American Orthopaedic Foot & Ankle Society, *SF-36 PCS* Short Form-36 Physical Component Summary, *VAS* visual analog scale, *ROM* range of motion**\***The independent *t* test was used to analyze age differences in all variables except range of motion. The Mann-Whitney *U* test was used to analyze differences in range of motion. A *p* value of \< 0.05 was considered significant†The values are given as the mean ± standard deviationFig. 1The mean preoperative and final follow-up clinical values are shown as bar graphs and the gap between the two values is the improvement value. The error bars indicate standard deviation. AOS, Ankle Osteoarthritis Scale; AOFAS, American Orthopaedic Foot and Ankle Society; SF-36 PCS, Short Form-36 Physical Component Summary; VAS, visual analog scale. \*Significant differences in SF-36 PCS scores between the two groups at the final follow-up

Radiographic outcomes {#Sec9}
---------------------

The radiographic outcome details are provided in Table [3](#Tab3){ref-type="table"}. The mean tibiotalar angle of each group was 8.5° and 11.0° preoperatively, and 3.6° and 4.0° at the final follow-up in men and women, respectively. Significant differences in the preoperative tibiotalar angle and improvement were observed between men and women (preoperative, *p* = 0.020; improvement, *p* = 0.014). However, there was no significant difference in the final follow-up tibiotalar angle (*p* = 0.226). Table 3Radiographic outcomes of men and women groupsMen (*N* = 109 ankles)Women (*N* = 86 ankles)*p* value\***Tibiotalar angle (°)**† Preoperative8.5 ± 6.6 (− 31.1 to 19.8)11.0 ± 6.8 (− 32.0 to 18.4)0.020 Final follow-up3.6 ± 2.1 (− 10.2 to 3.2)4.0 ± 2.2 (− 10.4 to 3.5)0.226 Improvement‡4.9 ± 6.3 (− 4.9 to 24.8)7.5 ± 6.5 (− 4.2 to 26.8)0.014**\***The independent *t* test was used to analyze age differences in tibiotalar angle. A *p* value of \< 0.05 was considered significant†The values are given as the mean ± standard deviation, with the range in parentheses. To reduce errors in the mean calculation due to positive (valgus) and negative (varus) values, these values are calculated as absolute values‡The improvement is given as the mean difference (preoperative minus final)

Complications and survivorship {#Sec10}
------------------------------

There were 19 ankles with complications in men, 20 ankles in women (Table [4](#Tab4){ref-type="table"}). The overall survivorship rate was 96.1%, at a mean follow-up of 7.5 years. There was no significant difference between the two groups (*p* = 0.621; log-rank test). Survivorship using Kaplan-Meier curves is shown in Fig. [2](#Fig2){ref-type="fig"}. Table 4Rate of complications associated with total ankle arthroplastyMen (*N* = 109 ankles)Women (*N* = 86 ankles)*p* value\***Major complications**†11 (10.1%)16 (18.6%)0.087 Deep infection1 (0.9%)‡-1.000 Periprosthetic osteolysis10 (9.2%)16 (18.6%)0.054  Alone6 (5.5%)11 (12.8%)0.073  With aseptic loosening-4 (4.7%)‡0.036  With component subsidence4 (3.7%)‡1 (1.2%)‡0.386**Minor complication**†8 (7.3%)4 (4.7%)0.109 Wound problem-1 (1.2%)0.441 Heterotopic ossification8 (7.3%)3 (3.5%)0.352**Total (no. \[%\])**19 (17.4%)20 (23.3%)0.459**\***The chi-square or Fisher's exact test was used to analyze differences in the number of complication. A *p* value of \< 0.05 was considered significant†The values are given as the number of ankles, with the percentage in parentheses‡These are failure cases that were revised with an exchange of the metallic componentFig. 2The Kaplan-Meier curve demonstrates the survivorship of total ankle arthroplasty (195 ankles), when the end point was defined as failure of the prosthesis. The overall survival probability of the implant was 96.1% (96.4% in the men's group and 93.4% in the women's group) at the mean follow-up of 7.5 years (*p* = 0.621)

There were 10 cases (5.1%) of failure that required exchange of a metallic component, due to deep infection (1 case), osteolysis with aseptic loosening (4 cases), and implant subsidence (5 cases). In the failures, 10 ankles were revised to another TAA or arthrodesis. Seventeen patients with periprosthetic osteolysis alone without loosening or subsidence underwent revision with curettage of an osteolytic lesion, bone grafting, and polyethylene exchange. In those cases, no further progression of osteolytic lesion was reported. Although statistically not significant, women showed higher prevalence of osteolysis and its associated complications compared with men.

One patient had wound problems; however, no one progressed to joint infection, and all healed without further surgical procedures. Three of eleven heterotopic ossification patients underwent resection of ossification due to severe pain.

Discussion {#Sec11}
==========

The most important aim of TAA is to provide an improved and pain-relieved ankle joint. Differences of operative outcomes for TAA between men and women could be expected, since there are differences in bone mineral density (BMD), the prevalence of generalized joint laxity, physical activity, and anatomic variations including alignment of lower extremity and bone size between the genders \[[@CR27], [@CR38]--[@CR42]\]. Thus, the primary purpose of this study was to compare the intermediate-term outcomes of TAA depending on gender difference. In this study, primary outcomes were greatly improved in both groups, but we did not find differences with most patient-reported outcomes, complication rates, and survivorship between the two groups. Consequently, those differences between men and women would not be considered as an affecting factor in the clinical outcomes.

Interestingly, unlike other clinical scores, SF-36 is more likely to have a higher score in men than women. Several studies have demonstrated outcome comparisons between men and women for SF-36 scores of the hip and knee \[[@CR26], [@CR28]\]. Cherian et al. analyzed 272 consecutive total knee arthroplasty and reported that the SF-36 PCS was significantly better in men at 7 years of follow-up \[[@CR28]\]. Khashan et al. suggested that gender-related analysis resulted in significantly higher scores for men compared to women in SF-36 scores for hip osteoarthritis patients \[[@CR26]\]. In regard to knee or hip, men have been reported to score significantly better in the SF-36 test. The activities of daily life have been extensively examined and some studies have reported that men were more tolerant of functional recovery and pain relief, while women on the other hand, tended to perceive their function and pain as more restrictive than they actually were \[[@CR25], [@CR43]\].

In terms of radiographic data, the preoperative tibiotalar angles were worse for women than men (Table [3](#Tab3){ref-type="table"}). Since there was a significant difference with tibiotalar angles between men and women before surgery, this was considered to be significantly improved by the process of intra-operative correction. Lee et al. reported that, regardless of preoperative deformity type or degree, if the tibiotalar angle of the ankle was corrected with any ligament imbalance or hindfoot deformity through an additional procedure, the TAA showed good outcomes \[[@CR22]\].

The survivorship rate was not significantly different between men and women at a mean follow-up of 7.5 years (96.4% and 93.4%, respectively) (*p* = 0.621) (Fig. [2](#Fig2){ref-type="fig"}). Gender had minimal effect on survival rates in TAA, perhaps attributable to the fact that there were no significant differences between the mean age at surgery (*p* = 0.114) or failure rates (*p* = 0.752) between men and women.

In the present study, prevalence of osteolysis and its associated complication was higher in women (16 cases, 18.6%) than in men (10 cases, 9.2%) (Table [4](#Tab4){ref-type="table"}). Men and women are known to have a difference in BMD due to multiple factors including hormonal differences, and we thought these differences may be associated with development of osteolysis. Morakis et al. reported that aseptic loosening was associated with a significant decrease of cortical bone and trabecular bone volumetric-BMD \[[@CR44]\]. Runolfsdottir et al. suggested that women had lower BMD than men, and a greater increase in BMD reductions with decreasing female hormones \[[@CR45]\]. In other words, the BMD difference between men and women suggests that women are more likely to develop aseptic loosening than men. However, gender was not a risk factor or prognostic factor for revision by aseptic loosening in total knee arthroplasty \[[@CR46]\]. Therefore, further studies on the relationship between the prevalence of osteolysis with aseptic loosening and bone mineral density are needed.

There were several weaknesses of our study. First, the present study was conducted retrospectively and the sample size of the two groups was relatively small. This may mitigate the ability to evaluate the influence of baseline characteristics on the outcomes and to detect a difference on this general subject. Second, the overall mean follow-up duration was 7.5 years. This might not be long enough to include late complications. Third, we performed computed tomography (CT) in some cases, but not all cases. Although plain radiograph is the basic assessment for osteolysis, some lesions may be missed or not detected. CT scan can improve the accuracy of the assessment of the development of osteolysis. Finally, this study did not further evaluate objective indicators such as BMD, generalized joint laxity, and whole lower extremity alignment.

Conclusions {#Sec12}
===========

In the intermediate-term follow-up, mobile-bearing total ankle arthroplasty showed similarly good clinical and radiographic outcomes in patients with ankle osteoarthritis, regardless of gender differences. These results suggest that gender did not seem affect outcomes of total ankle arthroplasty. Further studies with larger number of sample sizes and long-term follow-up are needed to clarify the effect of gender on outcomes.
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